{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:54:39Z","timestamp":1793386479745,"version":"4.5.0"},"reference-count":160,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s10072-019-04025-9","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T21:02:13Z","timestamp":1565211733000},"page":"2217-2234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Management of epilepsy in brain tumors"],"prefix":"10.1007","volume":"40","author":[{"name":"On behalf of Brain Tumor-related Epilepsy study group of Italian League Against Epilepsy (LICE)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3075-4108","authenticated-orcid":false,"given":"Marta","family":"Maschio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Aguglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Avanzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Banfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Buttinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Capovilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Maria Luisa","family":"Casazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Colicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Dainese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Daniele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marica","family":"Eoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Gasparini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Teresa","family":"Giallonardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"La Neve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Maialetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriano","family":"Mecarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Melis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Michelucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Paladin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Pauletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Piccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Quadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ranzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Salmaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Terenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Tisei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Vitali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucina Carla","family":"Vivalda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Zaccara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Zarabla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Beghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,7]]},"reference":[{"issue":"1","key":"4025_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1528-1157.1986.tb03499.x","volume":"27","author":"JK Annegers","year":"1986","unstructured":"Annegers JK (1986) Risk of recurrence after an initial unprovoked seizure. Epilepsia 27(1):43\u201350","journal-title":"Epilepsia"},{"issue":"1","key":"4025_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11060-014-1402-9","volume":"118","author":"SF Ansari","year":"2014","unstructured":"Ansari SF, Bohnstedt BN, Perkins SM, Althouse SK, Miller JC (2014) Efficacy of postoperative seizure prophylaxis in intra-axial brain tumor resections. J Neuro-Oncol 118(1):117\u2013122","journal-title":"J Neuro-Oncol"},{"key":"4025_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2377-14-152","volume":"14","author":"Y Arik","year":"2014","unstructured":"Arik Y, Leijten F, Seute T, Robe PA, Snijder TJ (2014) Prognosis and therapy of tumor-related versus non-tumor-related status epilepticus: a systematic review and meta-analysis. BMC Neurol 14:52","journal-title":"BMC Neurol"},{"key":"4025_CR4","unstructured":"Artsy E, Das R et al (2009) Discontinuation of antiepileptic drugs after surgery in low grade brain tumors. Epilepsia 50:56"},{"key":"4025_CR5","first-page":"57","volume":"2","author":"G Avanzini","year":"1983","unstructured":"Avanzini G, Battaglia G, Franceschetti S, Spreafico R (1983) Epilepsy as a symptom of cerebral tumors. Ital J Neurol Sci Suppl 2:57\u201361","journal-title":"Ital J Neurol Sci Suppl"},{"issue":"2","key":"4025_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00701-011-1144-9","volume":"154","author":"O B\u00e4hr","year":"2012","unstructured":"B\u00e4hr O, Hermisson M, Rona S, Rieger J, Nussbaum S, K\u00f6rtvelyessy P, Franz K, Tatagiba M, Seifert V, Weller M, Steinbach JP (2012) Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial. Acta Neurochir 154(2):229\u2013235","journal-title":"Acta Neurochir"},{"issue":"3","key":"4025_CR7","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ijrobp.2013.02.012","volume":"86","author":"C Barker","year":"2013","unstructured":"Barker C, Bishop AJ, Chang M, Beal K, Chan TA (2013) Valproic acid use during radiation therapy for glioblastoma associated with improved survival. Int J Radiat Oncol Biol Phys 86(3):504\u2013509","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"4025_CR8","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/ene.13375","volume":"24","author":"C Bedetti","year":"2017","unstructured":"Bedetti C, Romoli M, Maschio M, di Bonaventura C, Nardi Cesarini E, Eusebi P, Siliquini S, Dispenza S, Calabresi P, Costa C (2017) Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study. Eur J Neurol 24(10):1283\u20131289","journal-title":"Eur J Neurol"},{"issue":"5","key":"4025_CR9","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00415-017-8463-6","volume":"264","author":"V Belcastro","year":"2017","unstructured":"Belcastro V, Pisani LR, Bellocchi S, Casiraghi P, Gorgone G, Mula M, Pisani F (2017) Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study. J Neurol 264(5):921\u2013927","journal-title":"J Neurol"},{"issue":"2\u20133","key":"4025_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.eplepsyres.2008.07.012","volume":"82","author":"M Benifla","year":"2008","unstructured":"Benifla M, Rutka JT, Otsubo H, Lamberti-Pasculli M, Elliott I, Sell E, RamachandranNair R, Ochi A, Weiss SK, Snead OC III, Donner EJ (2008) Long-term seizure and social outcomes following temporal lobe surgery for intractable epilepsy during childhood. Epilepsy Res 82(2\u20133):133\u2013138","journal-title":"Epilepsy Res"},{"issue":"Suppl.1","key":"4025_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1528-1167.2008.01444.x","volume":"49","author":"AT Berg","year":"2008","unstructured":"Berg AT (2008) Risk of recurrence after a first unprovoked seizure. Epilepsia 49(Suppl.1):13\u201318","journal-title":"Epilepsia"},{"issue":"11","key":"4025_CR12","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/jcph.543","volume":"55","author":"AK Berg","year":"2015","unstructured":"Berg AK, Buckner JC, Galanis E, Jaeckle KA, Ames MM, Reid JM (2015) Quantification of the impact of enzyme inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposure. J Clin Pharmacol 55(11):1303\u20131312","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"4025_CR13","doi-asserted-by":"publisher","first-page":"Supplement S266","DOI":"10.1016\/j.ijrobp.2012.07.693","volume":"84","author":"AJ Bishop","year":"2012","unstructured":"Bishop AJ, Chang M, Yamada Y, Beal K, Barker CA (2012) Valproic acid use during radiation therapy for glioblastoma is associated with improved survival. Int J Radiat Oncol Biol Phys 84(3):Supplement S266","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4025_CR14","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/cncr.23741","volume":"113","author":"ML Bondy","year":"2008","unstructured":"Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il\u2019yasova D, Kruchko C, McCarthy B, Rajaraman P, Schwartzbaum JA, Sadetzki S, Schlehofer B, Tihan T, Wiemels JL, Wrensch M, Buffler PA, Brain Tumor Epidemiology Consortium (2008) Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113:1953\u20131968","journal-title":"Cancer"},{"issue":"1","key":"4025_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ana.24427","volume":"78","author":"K Boshuisen","year":"2015","unstructured":"Boshuisen K, van Schooneveld MM et al (2015) Intelligence quotient improves after antiepileptic drug withdrawal following pediatric epilepsy surgery. Ann Neurol 78(1):104\u2013114","journal-title":"Ann Neurol"},{"issue":"1","key":"4025_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1215\/15228517-2006-012","volume":"9","author":"I Bosma","year":"2007","unstructured":"Bosma I, Vos MJ, Heimans JJ, Taphoorn MJB, Aaronson NK, Postma TJ, van der Ploeg HM, Muller M, Vandertop WP, Slotman BJ, Klein M (2007) The course of neurocognitive functioning in high-grade glioma patients. Neuro-Oncology 9(1):53\u201362","journal-title":"Neuro-Oncology"},{"key":"4025_CR17","doi-asserted-by":"crossref","unstructured":"Bourg V, Lebrun C, Chichmanian RM, Thomas P, Frenay M (2001) Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity. Ann Oncol 12(2):217\u2013219","DOI":"10.1023\/A:1008331708395"},{"issue":"4","key":"4025_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/BF00165714","volume":"1","author":"TN Byrne","year":"1983","unstructured":"Byrne TN, Cascino TL, Posner JB (1983) Brain metastasis from melanoma. J Neuro-Oncol 1(4):313\u2013317","journal-title":"J Neuro-Oncol"},{"key":"4025_CR19","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11060-017-2660-0","volume":"136","author":"AF Cardona","year":"2018","unstructured":"Cardona AF, Rojas L, Wills B, Bernal L, Ruiz-Patino A, Arrieta O, Jim\u00e9nez Hakim E, Hakim F, Mej\u00eda JA, Useche N, Berm\u00fadez S, Carranza H, Vargas C, Otero J, Mayo LC, Ort\u00edz LD, Franco S, Ort\u00edz C, Gil-Gil M, Bala\u00f1a C, Zatarain-Barron ZL (2018) Efficacy and safety of levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma. J Neuro-Oncol 136:363\u2013371","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"4025_CR20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3171\/2009.2.JNS081132","volume":"111","author":"KL Chaichana","year":"2009","unstructured":"Chaichana KL, Parker SL et al (2009) Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. J Neurosurg 111(2):282\u2013292","journal-title":"J Neurosurg"},{"issue":"10","key":"4025_CR21","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1136\/jnnp.47.10.1087","volume":"47","author":"JB Chalk","year":"1984","unstructured":"Chalk JB, Ridgeway K, Brophy T, Yelland JD, Eadie MJ (1984) Phenytoin impairs the bioavailability of dexametasone in neurological and neurosurgical patients. J Neurol Neurosurg Psychiatry 47(10):1087\u20131090","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"4025_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3171\/JNS\/2008\/108\/2\/0227","volume":"108","author":"EF Chang","year":"2008","unstructured":"Chang EF, Potts MB, Keles GE, Lamborn KR, Chang SM, Barbaro NM, Berger MS (2008) Seizure characteristics and control following resection in 332 patients with low grade gliomas. J Neurosurg 108(2):227\u2013235","journal-title":"J Neurosurg"},{"key":"4025_CR23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","volume":"22","author":"Commission on Classification and Terminology of the International League against Epilepsy","year":"1981","unstructured":"Commission on Classification and Terminology of the International League against Epilepsy (1981) Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22:489\u2013501","journal-title":"Epilepsia"},{"issue":"3","key":"4025_CR24","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s11060-011-0779-y","volume":"107","author":"RR Das","year":"2012","unstructured":"Das RR, Artsy E, Hurwitz S, Wen PY, Black P, Golby A, Dworetzky B, Lee JW (2012) Outcome after discontinuation of antiepileptic drugs after surgery in patients with low grade tumors and meningiomas. J Neuro-Oncol 107(3):565\u2013570","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"4025_CR25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/neuonc\/nos288","volume":"15","author":"M de Groot","year":"2013","unstructured":"de Groot M, Douw L, Sizoo EM, Bosma I, Froklage FE, Heimans JJ, Postma TJ, Klein M, Reijneveld JC (2013) Levetiracetam improves verbal memory in high-grade glioma patients. Neuro-Oncology 15(2):216\u2013223","journal-title":"Neuro-Oncology"},{"key":"4025_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.seizure.2017.08.009","volume":"51","author":"C Di Bonaventura","year":"2017","unstructured":"Di Bonaventura C, Albini M et al (2017) Epileptic seizures heralding a relapse in high grade gliomas. Seizure 51:157\u2013162","journal-title":"Seizure"},{"key":"4025_CR27","volume-title":"Clinical practice guideline process manual","author":"W Edlund","year":"2005","unstructured":"Edlund W, Gronseth G, So Y, Franklin G (2005) Clinical practice guideline process manual. American Academy of Neurology, Minnesota"},{"issue":"7","key":"4025_CR28","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3109\/08880018.2011.563774","volume":"28","author":"FH Felix","year":"2011","unstructured":"Felix FH, Trompieri NM, de Araujo OL, da Trindade KM, Fontenele JB (2011) Potential role for valproate in the treatment of high-risk brain tumors of childhood\u2014results from a retrospective observational cohort study. Pediatr Hematol Oncol 28(7):556\u2013570","journal-title":"Pediatr Hematol Oncol"},{"issue":"4","key":"4025_CR29","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","volume":"46","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46(4):765\u2013781","journal-title":"Eur J Cancer"},{"issue":"4","key":"4025_CR30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/epi.12550","volume":"55","author":"RS Fisher","year":"2014","unstructured":"Fisher RS (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55(4):475\u2013482","journal-title":"Epilepsia"},{"key":"4025_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1468-1331.2004.00992.x","volume":"12","author":"L Forsgren","year":"2005","unstructured":"Forsgren L, Beghi E, Oun A, Sillanpaa M (2005) The epidemiology of epilepsy in Europe \u2013 a systematic review. Eur J Neurol 12:245\u2013253","journal-title":"Eur J Neurol"},{"issue":"2","key":"4025_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1017\/S0317167100053361","volume":"30","author":"PA Forsyth","year":"2003","unstructured":"Forsyth PA, Weaver S, Fulton D, Brasher PMA, Sutherland G, Stewart D, Hagen NA, Barnes P, Cairncross JG, DeAngelis LM (2003) Prophylactic anticonvulsants in patients with brain tumour. Can J Neurol Sci 30(2):106\u2013112","journal-title":"Can J Neurol Sci"},{"issue":"12","key":"4025_CR33","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1055\/s-0034-1385475","volume":"82","author":"W Fr\u00f6scher","year":"2014","unstructured":"Fr\u00f6scher W et al (2014) Anticonvulsant therapy for brain tumour-related epilepsy. Fortschr Neurol Psychiatr 82(12):678\u2013690","journal-title":"Fortschr Neurol Psychiatr"},{"issue":"2","key":"4025_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4103\/0028-3886.111118","volume":"61","author":"D Garbossa","year":"2013","unstructured":"Garbossa D, Panciani PP, Angeleri R, Battaglia L, Tartara F, Ajello M, Agnoletti A, Versari P, Ducati A, Fontanella M, Spena G (2013) A retrospective two-center study of antiepileptic prophylaxis in patients with surgically treated high-grade gliomas. Neurol India 61(2):131\u2013137","journal-title":"Neurol India"},{"issue":"8","key":"4025_CR35","first-page":"2940","volume":"9","author":"MR Gilbert","year":"2003","unstructured":"Gilbert MR et al (2003) Phase I clinical and pharmacokinetic study of irinotecan in adults with recurrent malignant glioma. Clin Cancer Res 9(8):2940\u20132949","journal-title":"Clin Cancer Res"},{"issue":"4","key":"4025_CR36","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1212\/WNL.46.4.985","volume":"46","author":"MJ Glantz","year":"1996","unstructured":"Glantz MJ, Cole BF, Friedberg MH, Lathi E, Choy H, Furie K, Akerley W, Wahlberg L, Lekos A, Louis S (1996) A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology 46(4):985\u2013991","journal-title":"Neurology"},{"issue":"10","key":"4025_CR37","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1212\/WNL.54.10.1886","volume":"54","author":"MJ Glantz","year":"2000","unstructured":"Glantz MJ, Cole BF et al (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54(10):1886\u20131893","journal-title":"Neurology"},{"issue":"4","key":"4025_CR38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/1793-5482.125658","volume":"8","author":"S Gokhale","year":"2013","unstructured":"Gokhale S, Khan SA, McDonagh DL, Agrawal A, Friedman AH (2013) Levetiracetam seizure prophylaxis in craniotomy patients at high risk for postoperative seizures. Asian J Neurosurg 8(4):169\u2013173","journal-title":"Asian J Neurosurg"},{"issue":"1","key":"4025_CR39","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11060-012-0802-y","volume":"108","author":"SA Goldlust","year":"2012","unstructured":"Goldlust SA, Hsu M, Lassman AB, Panageas KS, Avila EK (2012) Seizure prophylaxis and melanoma brain metastases. J Neuro-Oncol 108(1):109\u2013114","journal-title":"J Neuro-Oncol"},{"issue":"5","key":"4025_CR40","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3171\/2014.7.JNS132657","volume":"121","author":"T Gonen","year":"2014","unstructured":"Gonen T, Grossman R, Sitt R, Nossek E, Yanaki R, Cagnano E, Korn A, Hayat D, Ram ZJ (2014) Tumor location and IDH1 mutation may predict intraoperative seizures during awake craniotomy. Neurosurg. 121(5):1133\u20131138","journal-title":"Neurosurg."},{"issue":"2","key":"4025_CR41","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1215\/15228517-2007-055","volume":"10","author":"SA Grossman","year":"2008","unstructured":"Grossman SA (2008) Effect of phenytoin on celecoxib pharmacokinetics in patients with glioblastoma. Neuro-Oncology 10(2):190\u2013198","journal-title":"Neuro-Oncology"},{"issue":"2","key":"4025_CR42","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s002800050794","volume":"42","author":"SA Grossman","year":"1998","unstructured":"Grossman SA, Hochberg F et al (1998) Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants. NABTT CNS Consortium. The new approaches to brain tumor therapy. Cancer Chemother Pharmacol 42(2):118\u2013126","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"4025_CR43","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.euroneuro.2011.08.008","volume":"21","author":"A Gustavsson","year":"2011","unstructured":"Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, J\u00f6nsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen HC, Stovner LJ, Vallat JM, van den Bergh P, van Os J, Vos P, Xu W, Wittchen HU, J\u00f6nsson B, Olesen J, CDBE2010Study Group (2011) CDBE2010 Study Group. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21(10):718\u2013779","journal-title":"Eur Neuropsychopharmacol"},{"key":"4025_CR44","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3171\/2012.10.JNS12169","volume":"118","author":"GD Guthrie","year":"2013","unstructured":"Guthrie GD, Eljamel S (2013) Impact of particular antiepileptic drugs on the survival of patients with glioblastoma multiforme. J Neurosurg 118:859\u2013865","journal-title":"J Neurosurg"},{"key":"4025_CR45","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1200\/JCO.2015.63.6563","volume":"34","author":"C Happold","year":"2016","unstructured":"Happold C, Gorlia T, Chinot O, Gilbert MR, Nabors LB, Wick W, Pugh SL, Hegi M, Cloughesy T, Roth P, Reardon DA, Perry JR, Mehta MP, Stupp R, Weller M (2016) Does valproic acid or levetiracetam improve survival in glioblastoma? A pooled analysis of prospective clinical trials in newly diagnosed glioblastoma. J Clin Oncol 34:731\u2013739","journal-title":"J Clin Oncol"},{"issue":"6","key":"4025_CR46","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3171\/2011.3.PEDS1120","volume":"7","author":"DA Hardesty","year":"2011","unstructured":"Hardesty DA, Sanborn MR, Parker WE, Storm PB (2011) Perioperative seizure incidence and risk factors in 223 pediatric brain tumor patients without prior seizures. J Neurosurg Pediatr 7(6):609\u2013615","journal-title":"J Neurosurg Pediatr"},{"issue":"5","key":"4025_CR47","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.clpt.2004.07.016","volume":"76","author":"F Innocenti","year":"2004","unstructured":"Innocenti F et al (2004) A phase I clinical trial of pharmacologic modulation of irinotecan with cyclosporine and phenobarbital. Clin Pharmacol Ther 76(5):490\u2013502","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"4025_CR48","first-page":"149","volume":"31","author":"AI Islim","year":"2017","unstructured":"Islim AI, McKeever S et al (2017) The role of prophylactic antiepileptic drugs for seizure prophylaxis in meningioma surgery: a systematic review. Br J Neurosurg 31(2):149","journal-title":"Br J Neurosurg"},{"issue":"1","key":"4025_CR49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jocn.2014.05.036","volume":"22","author":"T Iuchi","year":"2015","unstructured":"Iuchi T, Hasegawa Y, Kawasaki K, Sakaida T (2015) Epilepsy in patients with gliomas: incidence and control of seizures. J Clin Neurosci 22(1):87\u201391","journal-title":"J Clin Neurosci"},{"key":"4025_CR50","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1212\/WNL.0b013e3181bbfeca","volume":"73","author":"KA Jaeckle","year":"2009","unstructured":"Jaeckle KA, Ballman K, Furth A, Buckner JC (2009) Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma. Neurology 73:1207\u20131213","journal-title":"Neurology"},{"issue":"4","key":"4025_CR51","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1046\/j.1528-1157.2001.31400.x","volume":"42","author":"P Jallon","year":"2001","unstructured":"Jallon P (2001) Newly diagnosed unprovoked epileptic seizures: presentation at diagnosis in CAROLE study. Epilepsia 42(4):464\u2013475","journal-title":"Epilepsia"},{"key":"4025_CR52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1684\/j.1950-6945.2002.tb00430.x","volume":"4","author":"P Jallon","year":"2002","unstructured":"Jallon P (2002) Epilepsy and epileptic disorders, an epidemiological marker? Contribution of descriptive epidemiology. Epileptic Disord 4:11\u201313","journal-title":"Epileptic Disord"},{"key":"4025_CR53","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00280-011-1569-0","volume":"67","author":"O Kargiotis","year":"2011","unstructured":"Kargiotis O, Markoula S, Kyritsis AP (2011) Epilepsy in the cancer patient. Cancer Chemother Pharmacol 67:489\u2013501","journal-title":"Cancer Chemother Pharmacol"},{"issue":"Suppl.9","key":"4025_CR54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/epi.12437","volume":"54","author":"M Kerkhof","year":"2013","unstructured":"Kerkhof M, Dielemans JC, van Breemen MS, Zwinkels H, Walchenbach R, Taphoorn MJ, Vecht CJ (2013) Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme. Epilepsia 54(Suppl.9):12\u201317","journal-title":"Epilepsia"},{"key":"4025_CR55","doi-asserted-by":"publisher","first-page":"iv61","DOI":"10.1093\/neuonc\/now188.215","volume":"18","author":"M Kerkhof","year":"2016","unstructured":"Kerkhof M, Koekkoek JAF et al (2016) Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom. Neuro-Oncology 18:iv61","journal-title":"Neuro-Oncology"},{"key":"4025_CR56","first-page":"CD008586","volume":"8","author":"S Kerrigan","year":"2011","unstructured":"Kerrigan S, Grant R (2011) Antiepileptic drugs for treating seizures in adults with brain tumors. Cochrane Database Syst 8:CD008586","journal-title":"Cochrane Database Syst"},{"issue":"2","key":"4025_CR57","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1528-1167.2006.00431.x","volume":"47","author":"RB Khan","year":"2006","unstructured":"Khan RB, Onar A (2006) Seizure recurrence and risk factors after antiepilepsy drug withdrawal in children with brain tumors. Epilepsia 47(2):375\u2013379","journal-title":"Epilepsia"},{"key":"4025_CR58","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/cncr.29439","volume":"1","author":"YH Kim","year":"2015","unstructured":"Kim YH, Kim T, Joo J, Ho Han J, Kim YJ, Kim IA, Yun C, Kim C (2015) Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme. Cancer 1:2926\u20132932","journal-title":"Cancer"},{"issue":"9343","key":"4025_CR59","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/S0140-6736(02)11398-5","volume":"360","author":"M Klein","year":"2002","unstructured":"Klein M, Heimans JJ, Aaronson NK, van der Ploeg HM, Grit J, Muller M, Postma TJ, Mooij JJ, Boerman RH, Beute GN, Ossenkoppele GJ, van Imhoff GW, Dekker AW, Jolles J, Slotman BJ, Struikmans H, Taphoorn MJ (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360(9343):1361\u20131368","journal-title":"Lancet"},{"issue":"4","key":"4025_CR60","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/ana.10712","volume":"54","author":"M Klein","year":"2003","unstructured":"Klein M, Engelberts NH et al (2003) Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 54(4):514\u2013520","journal-title":"Ann Neurol"},{"key":"4025_CR61","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11060-016-2191-0","volume":"129","author":"KM Knudsen-Baas","year":"2016","unstructured":"Knudsen-Baas KM, Engeland A, Gilhus NE, Storstein AM, Owe JF (2016) Does the choice of antiepileptic drug affect survival in glioblastoma patients? J Neuro-Oncol 129:461\u2013469","journal-title":"J Neuro-Oncol"},{"key":"4025_CR62","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12883-014-0157-4","volume":"14","author":"J Koekkoek","year":"2014","unstructured":"Koekkoek J et al (2014) Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study. BMC Neurol 14:157","journal-title":"BMC Neurol"},{"issue":"4","key":"4025_CR63","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/jnnp-2014-308136","volume":"86","author":"JA Koekkoek","year":"2015","unstructured":"Koekkoek JA, Dirven L, Heimans JJ, Postma TJ, Vos MJ, Reijneveld JC, Taphoorn MJ (2015) Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomide. J Neurol Neurosurg Psychiatry 86(4):366\u2013373","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"4025_CR64","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/14737175.2016.1219250","volume":"17","author":"JA Koekkoek","year":"2017","unstructured":"Koekkoek JA et al (2017) The withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma. Expert Rev Neurother 17(2):193\u2013202","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"4025_CR65","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3171\/2011.4.JNS101585","volume":"115","author":"RJ Komotar","year":"2011","unstructured":"Komotar RJ, Raper DM, Starke RM, Iorgulescu JB, Gutin PH (2011) Prophylactic antiepileptic drug therapy in patients undergoing supratentorial meningioma resection: a systematic analysis of efficacy. J Neurosurg 115(3):483\u2013490","journal-title":"J Neurosurg"},{"key":"4025_CR66","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.clineuro.2015.04.010","volume":"134","author":"X Kong","year":"2015","unstructured":"Kong X, Guan J, Yang Y, Li Y, Ma W, Wang R (2015) A meta-analysis: do prophylactic antiepileptic drugs in patients with brain tumors decrease the incidence of seizures? Clin Neurol Neurosurg 134:98\u2013103","journal-title":"Clin Neurol Neurosurg"},{"issue":"5","key":"4025_CR67","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ijrobp.2015.04.038","volume":"92","author":"AV Krauze","year":"2015","unstructured":"Krauze AV, Myrehaug SD, Chang MG, Holdford DJ, Smith S, Shih J, Tofilon PJ, Fine HA, Camphausen K (2015) A phase 2 study of concurrent radiation therapy, temozolomide, and the histone deacetylase inhibitor valproic acid for patients with glioblastoma. Int J Radiat Oncol Biol Phys 92(5):986\u2013992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"17","key":"4025_CR68","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1212\/01.wnl.0000473351.32413.7c","volume":"85","author":"A Krumholz","year":"2015","unstructured":"Krumholz A (2015) Evidence-based guideline: management of an unprovoked first seizure in adults: report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 85(17):1526\u20131527","journal-title":"Neurology"},{"issue":"8 Suppl 7","key":"4025_CR69","first-page":"33","volume":"16","author":"JG Kuhn","year":"2002","unstructured":"Kuhn JG (2002) Influence of anticonvulsants on the metabolism and elimination of irinotecan. A North American Brain Tumor Consortium preliminary report. Oncology 16(8 Suppl 7):33\u201340","journal-title":"Oncology"},{"issue":"24","key":"4025_CR70","doi-asserted-by":"publisher","first-page":"7401","DOI":"10.1158\/1078-0432.CCR-07-0781","volume":"13","author":"JG Kuhn","year":"2007","unstructured":"Kuhn JG (2007) Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma. Clin Cancer Res 13(24):7401\u20137406","journal-title":"Clin Cancer Res"},{"key":"4025_CR71","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1136\/jnnp.2004.045690","volume":"75","author":"P Kwan","year":"2004","unstructured":"Kwan P, Sander JW (2004) The natural history of epilepsy: an epidemiological view. Neurol Neurosurg Psychiatry 75:1376\u20131381","journal-title":"Neurol Neurosurg Psychiatry"},{"issue":"4","key":"4025_CR72","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/nop\/npv018","volume":"2","author":"S Lapointe","year":"2015","unstructured":"Lapointe S, Florescu M, Nguyen DK, Djeffal C, B\u00e9langer K (2015) Prophylactic anticonvulsants for gliomas: a seven-year retrospective analysis. Neuro-Oncology Pract 2(4):192\u2013198","journal-title":"Neuro-Oncology Pract"},{"issue":"10","key":"4025_CR73","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s00701-013-1826-6","volume":"155","author":"MH Lee","year":"2013","unstructured":"Lee MH, Kong DS, Seol HJ, Nam DH, Lee JI (2013) Risk of seizure and its clinical implication in the patients with cerebral metastasis from lung cancer. Acta Neurochir 155(10):1833\u20131837","journal-title":"Acta Neurochir"},{"issue":"2","key":"4025_CR74","doi-asserted-by":"publisher","first-page":"E88","DOI":"10.1016\/j.ijrobp.2017.06.801","volume":"99","author":"PY Lee","year":"2017","unstructured":"Lee PY, Wei YT, Liang JA, Kuo YC, Chen LC, Chu CN (2017) Controversy in anti-epileptic drug as radio-sensitizer to improve survival in high grade malignant glioma: a nationwide population-based cohort study. Int J Radiat Oncol Biol Phys 99(2):E88","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4025_CR75","unstructured":"Levy G, Lervat C et al (2016) Bicentric retrospective observational study on the use of anti-epileptic drugs in children with brain tumors. Pediatr Blood Cancer 63"},{"issue":"7","key":"4025_CR76","doi-asserted-by":"publisher","first-page":"e0158206","DOI":"10.1371\/journal.pone.0158206","volume":"11","author":"S Liang","year":"2016","unstructured":"Liang S, Zhang J, Zhang S, Fu X (2016) Epilepsy in adults with supratentorial glioblastoma: incidence and influence factors and prophylaxis in 184 patients. PLoS One 11(7):e0158206","journal-title":"PLoS One"},{"key":"4025_CR77","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11060-008-9781-4","volume":"93","author":"DA Lim","year":"2009","unstructured":"Lim DA, Tarapore P, Chang E, Burt M, Chakalian L, Barbaro N, Chang S, Lamborn KR, McDermott MW (2009) Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. J Neuro-Oncol 93:349\u2013354","journal-title":"J Neuro-Oncol"},{"issue":"Suppl1","key":"4025_CR78","doi-asserted-by":"publisher","first-page":"e6871","DOI":"10.5867\/medwave.2017.6871","volume":"17","author":"D Lobos-Urbina","year":"2017","unstructured":"Lobos-Urbina D, Kittsteiner-Manubens L, Pe\u00f1a J (2017) Is primary prevention with antiepileptic drugs effective in brain tumors or brain metastases? Medwave 17(Suppl1):e6871","journal-title":"Medwave"},{"key":"4025_CR79","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.wneu.2016.10.079","volume":"98","author":"DT Lockney","year":"2017","unstructured":"Lockney DT, Vaziri S, Walch F, Kubilis P, Neal D, Murad GJA, Rahman M (2017) Prophylactic antiepileptic drug use in patients with brain tumors undergoing craniotomy. World Neurosurg 98:28\u201333","journal-title":"World Neurosurg"},{"issue":"23","key":"4025_CR80","doi-asserted-by":"publisher","first-page":"7133","DOI":"10.1158\/1078-0432.CCR-07-0874","volume":"13","author":"ME Loghin","year":"2007","unstructured":"Loghin ME (2007) Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a North American brain tumor consortium study. Clin Cancer Res 13(23):7133\u20137138","journal-title":"Clin Cancer Res"},{"issue":"3","key":"4025_CR81","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11060-009-9977-2","volume":"96","author":"S Lwu","year":"2010","unstructured":"Lwu S, Hamilton MG, Forsyth PA, Cairncross JG, Parney IF (2010) Use of peri-operative anti-epileptic drugs in patients with newly diagnosed high grade malignant glioma: a single center experience. J Neuro-Oncol 96(3):403\u2013408","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"4025_CR82","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11060-006-9162-9","volume":"80","author":"M Maschio","year":"2006","unstructured":"Maschio M, Albani F, Baruzzi A (2006) Levetiracetam therapy in patients with brain tumour and epilepsy. J Neuro-Oncol 80(1):97\u2013100","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"4025_CR83","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11060-007-9430-3","volume":"86","author":"M Maschio","year":"2008","unstructured":"Maschio M, Dinapoli L, Zarabla A, Pompili A, Carapella CM, Pace A, Giannarelli D, Occhipinti E, Jandolo B (2008) Outcome and tolerability of topiramate in brain tumor associated epilepsy. J Neuro-Oncol 86(1):61\u201370","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"4025_CR84","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1756-9966-28-60","volume":"28","author":"M Maschio","year":"2009","unstructured":"Maschio M, Dinapoli L, Vidiri A, Pace A, Fabi A, Pompili A, Carapella MC, Jandolo B (2009) The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine. J Exp Clin Cancer Res 28(1):60","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4025_CR85","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11060-009-0069-0","volume":"98","author":"M Maschio","year":"2010","unstructured":"Maschio M, Dinapoli L, Gomellini S, Ferraresi V, Sperati F, Vidiri A, Muti P, Jandolo B (2010) Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy. J Neuro-Oncol 98(1):109\u2013116","journal-title":"J Neuro-Oncol"},{"key":"4025_CR86","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11060-010-0460-x","volume":"104","author":"M Maschio","year":"2011","unstructured":"Maschio M, Dinapoli L, Sperati F, Pace A, Fabi A, Vidiri A, Muti P (2011) Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life. J Neuro-Oncol 104:205\u2013214","journal-title":"J Neuro-Oncol"},{"key":"4025_CR87","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1007\/s00415-011-6132-8","volume":"258","author":"M Maschio","year":"2011","unstructured":"Maschio M, Dinapoli L, Mingoia M, Sperati F, Pace A, Pompili A, Carapella CM, Vidiri A, Muti P (2011) Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability. J Neurol 258:2100\u20132104","journal-title":"J Neurol"},{"key":"4025_CR88","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s11060-011-0689-z","volume":"106","author":"M Maschio","year":"2012","unstructured":"Maschio M, Dinapoli L, Sperati F, Fabi A, Pace A, Vidiri A, Muti P (2012) Oxcarbazepine monotherapy in patients with brain tumor-related epilepsy: open-label pilot study for assessing the efficacy, tolerability and impact on quality of life. J Neuro-Oncol 106:651\u2013656","journal-title":"J Neuro-Oncol"},{"key":"4025_CR89","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1684\/epd.2012.0542","volume":"14","author":"M Maschio","year":"2012","unstructured":"Maschio M, Dinapoli L, Sperati F, Pace A, Fabi A, Vidiri A, Pompili A, Carapella CM (2012) Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study. Epileptic Disord 14:388\u2013397","journal-title":"Epileptic Disord"},{"issue":"2","key":"4025_CR90","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11060-014-1449-7","volume":"118","author":"M Maschio","year":"2014","unstructured":"Maschio M, Sperati F, Dinapoli L, Vidiri A, Fabi A, Pace A, Pompili A, Carapella CM, Cantelmi T (2014) Weight of epilepsy in brain tumor patients. J Neuro-Oncol 118(2):385\u2013393","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"4025_CR91","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10072-014-1887-1","volume":"36","author":"M Maschio","year":"2015","unstructured":"Maschio M, Paladin F, on behalf of the LICE brain tumor-related epilepsy study group (2015) Taking care of patients with brain tumor-related epilepsy: results from an Italian survey. Neurol Sci 36(1):125\u2013130","journal-title":"Neurol Sci"},{"key":"4025_CR92","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/WNF.0000000000000218","volume":"40","author":"M Maschio","year":"2017","unstructured":"Maschio M, Dinapoli L, Zarabla A, Maialetti A, Giannarelli D, Fabi A, Vidiri A, Cantelmi T (2017) Zonisamide in brain tumor-related epilepsy: an observational pilot study. Clin Neuropharmacol 40:113\u2013119","journal-title":"Clin Neuropharmacol"},{"key":"4025_CR93","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.yebeh.2017.05.031","volume":"73","author":"M Maschio","year":"2017","unstructured":"Maschio M, Zarabla A, Maialetti A, Fabi A, Vidiri A, Villani V, Giannarelli D (2017) Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: a prospective explorative study with a historical control group. Epilepsy Behav 73:83\u201389","journal-title":"Epilepsy Behav"},{"issue":"7","key":"4025_CR94","doi-asserted-by":"publisher","first-page":"e0180470","DOI":"10.1371\/journal.pone.0180470","volume":"12","author":"M Maschio","year":"2017","unstructured":"Maschio M, Beghi E, Casazza MML et al (2017) Patterns of care of brain tumor-related epilepsy. A cohort study done in Italian Epilepsy Center. PLoS One 12(7):e0180470","journal-title":"PLoS One"},{"key":"4025_CR95","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3171\/2010.5.JNS091367","volume":"113","author":"RT Merrel","year":"2010","unstructured":"Merrel RT, Anderson SK, Meyer FB, Lachance DH (2010) Seizures in patients with glioma treated with phenytoin and levetiracetam. J Neurosurg 113:1176\u20131181","journal-title":"J Neurosurg"},{"issue":"3","key":"4025_CR96","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3171\/PED\/2008\/1\/3\/206","volume":"1","author":"K Minkin","year":"2008","unstructured":"Minkin K, Klein O, Mancini J, Lena G (2008) Surgical strategies and seizure control in pediatric patients with dysembryoplastic neuroepithelial tumors: a single-institution experience. J Neurosurg Pediatr 1(3):206\u2013210","journal-title":"J Neurosurg Pediatr"},{"issue":"7","key":"4025_CR97","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1200\/JCO.1994.12.7.1468","volume":"12","author":"K Mross","year":"1994","unstructured":"Mross K, Bewermeier P, Kr\u00fcger W, Stockschl\u00e4der M, Zander A, Hossfeld DK (1994) Pharmacokinetics of undiluted or diluted high-dose etoposide with or without busulfan administered to patients with hematologic malignancies. J Clin Oncol 12(7):1468\u20131474","journal-title":"J Clin Oncol"},{"key":"4025_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-016-2146-5","volume":"129","author":"ZG Nasr","year":"2016","unstructured":"Nasr ZG, Paravattil B, Wilby KJ (2016) Levetiracetam for seizure prevention in brain tumor patients: a systematic review. J Neuro-Oncol 129:1\u201313","journal-title":"J Neuro-Oncol"},{"key":"4025_CR99","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11060-005-9070-4","volume":"78","author":"HB Newton","year":"2006","unstructured":"Newton HB, Goldlust SA, Pearl D (2006) Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neuro-Oncol 78:99\u2013102","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"4025_CR100","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.clineuro.2008.09.009","volume":"111","author":"J Novy","year":"2009","unstructured":"Novy J, Stupp R, Rossetti AO (2009) Pregabalin in patients with primary brain tumors and seizures: a preliminary observation. Clin Neurol Neurosurg 111(2):171\u2013173","journal-title":"Clin Neurol Neurosurg"},{"key":"4025_CR101","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11060-004-2338-2","volume":"72","author":"S Oberndorfer","year":"2005","unstructured":"Oberndorfer S, Piribauer M, Marosi C, Lahrmann H, Hitzenberger P, Grisold W (2005) P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neuro-Oncol 72:255\u2013260","journal-title":"J Neuro-Oncol"},{"key":"4025_CR102","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11910-011-0189-8","volume":"11","author":"QT Ostrom","year":"2011","unstructured":"Ostrom QT, Barnholtz-Sloan JS (2011) Current state of our knowledge on brain tumor epidemiology. Curr Neurol Neurosci Rep 11:329\u2013335","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"4025_CR103","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1017\/S0317167100038853","volume":"23","author":"JR Perry","year":"1996","unstructured":"Perry JR, Sawka C (1996) Add-on gabapentin for refractory seizures in patients with brain tumours. Can J Neurol Sci 23(2):128\u2013131","journal-title":"Can J Neurol Sci"},{"issue":"6","key":"4025_CR104","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3747\/co.v13i6.107","volume":"13","author":"J Perry","year":"2006","unstructured":"Perry J, Zinman L, Chambers A, Spithoff K, Lloyd N, Laperriere N, Neuro-oncology Disease Site Group, Cancer Care Ontario\u2019s Program in Evidence-Based Care (2006) The use of prophylactic anticonvulsants in patients with brain tumours - a systematic review. Curr Oncol 13(6):222\u2013229","journal-title":"Curr Oncol"},{"issue":"Suppl 9","key":"4025_CR105","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/epi.12452","volume":"54","author":"E Perucca","year":"2013","unstructured":"Perucca E (2013) Optimizing antiepileptic drug treatment in tumoral epilepsy. Epilepsia. 54(Suppl 9):97\u2013104","journal-title":"Epilepsia."},{"issue":"24","key":"4025_CR106","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1002\/cncr.24666","volume":"115","author":"JH Phi","year":"2009","unstructured":"Phi JH, Kim SK, Cho BK, Lee SY, Park SY, Park SJ, Lee SK, Kim KJ, Chung CK (2009) Long-term surgical outcomes of temporal lobe epilepsy associated with low-grade brain tumors. Cancer 115(24):5771\u20135779","journal-title":"Cancer"},{"issue":"2","key":"4025_CR107","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1215\/S1152851704000183","volume":"7","author":"S Phuphanich","year":"2005","unstructured":"Phuphanich S, Baker SD, Grossman SA, Carson KA, Gilbert MR, Fisher JD, Carducci MA (2005) Oral sodium phenylbutyrate in patients with recurrent malignant gliomas: a dose escalation and pharmacologic study. Neuro-Oncology 7(2):177\u2013182","journal-title":"Neuro-Oncology"},{"issue":"1","key":"4025_CR108","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1215\/S1522851705000451","volume":"8","author":"MD Prados","year":"2006","unstructured":"Prados MD (2006) Phase I study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma. Neuro-Oncology 8(1):67\u201378","journal-title":"Neuro-Oncology"},{"issue":"12","key":"4025_CR109","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1111\/j.1528-1167.2007.01251.x","volume":"48","author":"M Pugliatti","year":"2007","unstructured":"Pugliatti M, Beghi E, Forsgren L, Ekman M, Sobocki P (2007) Estimating the cost of epilepsy in Europe: a review with economic modeling. Epilepsia 48(12):2224\u20132233","journal-title":"Epilepsia"},{"issue":"3","key":"4025_CR110","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2174\/157488408785747656","volume":"3","author":"S Pursche","year":"2008","unstructured":"Pursche S (2008) Influence of enzyme-inducing antiepileptic drugs on trough level of imatinib in glioblastoma patients. Curr Clin Pharmacol 3(3):198\u2013203","journal-title":"Curr Clin Pharmacol"},{"key":"4025_CR111","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.clineuro.2005.10.014","volume":"108","author":"A Radhakrishnan","year":"2006","unstructured":"Radhakrishnan A, Abraham M, Radhakrishnan VV, Sarma SP, Radhakrishnan K (2006) Medically refractory epilepsy associated with temporal lobe ganglioglioma: characteristics and postoperative outcome. Clin Neurol Neurosurg 108:648\u2013654","journal-title":"Clin Neurol Neurosurg"},{"key":"4025_CR112","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.clineuro.2015.12.020","volume":"141","author":"A Radhakrishnan","year":"2016","unstructured":"Radhakrishnan A, Abraham M, Vilanilam G, Menon R, Menon D, Kumar H, Cherian A, Radhakrishnan N, Kesavadas C, Thomas B, Sarma SP, Thomas SV (2016) Surgery for \u201clong-term epilepsy associated tumors (LEATs)\u201d: seizure outcome and its predictors. Clin Neurol Neurosurg 141:98\u2013105","journal-title":"Clin Neurol Neurosurg"},{"key":"4025_CR113","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.yebeh.2015.03.016","volume":"48","author":"Z Rahman","year":"2015","unstructured":"Rahman Z, Wong CH, Dexter M, Olsson G, Wong M, Gebsky V, Nahar N, Wood A, Byth K, King M, Bleasel AB (2015) Epilepsy in patients with primary brain tumors: the impact on mood, cognition, and HRQOL. Epilepsy Behav 48:88\u201395","journal-title":"Epilepsy Behav"},{"key":"4025_CR114","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s11060-016-2054-8","volume":"127","author":"N Redjal","year":"2016","unstructured":"Redjal N, Clemens Reinshagen C, Le A, Walcott BP, McDonnell E, Dietrich J, Nahed BV (2016) Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II\/III gliomas treated with temozolomide. J Neuro-Oncol 127:505\u2013514","journal-title":"J Neuro-Oncol"},{"issue":"12","key":"4025_CR115","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1177\/1060028016661572","volume":"50","author":"D Reeves","year":"2016","unstructured":"Reeves D, DiDominick S, Finn S, Kim HJ, Shake A (2016) Methotrexate elimination when coadministered with levetiracetam. Ann Pharmacother 50(12):1016\u20131022","journal-title":"Ann Pharmacother"},{"issue":"3","key":"4025_CR116","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1023\/A:1006404825356","volume":"48","author":"M Riva","year":"2000","unstructured":"Riva M, Landonio G, Siena S, Defanti CA (2000) The effect of anticonvulsant drugs on blood levels of methotrexate. J Neuro-Oncol 48(3):249\u2013250","journal-title":"J Neuro-Oncol"},{"issue":"11","key":"4025_CR117","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1200\/JCO.1994.12.11.2390","volume":"12","author":"JH Rodman","year":"1994","unstructured":"Rodman JH, Murry DJ, Madden T, Santana VM (1994) Altered etoposide pharmacokinetics and time to engrafment in pediatric patients undergoing autologous bone marrow transplantation. J Clin Oncol 12(11):2390\u20132397","journal-title":"J Clin Oncol"},{"issue":"5","key":"4025_CR118","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/neuonc\/nov282","volume":"18","author":"U Roelcke","year":"2016","unstructured":"Roelcke U, Wyss MT, Nowosielski M, Rud\u00e0 R, Roth P, Hofer S, Galldiks N, Crippa F, Weller M, Soffietti R (2016) Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas. Neuro-Oncology 18(5):744\u2013751","journal-title":"Neuro-Oncology"},{"issue":"3","key":"4025_CR119","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s11060-009-9796-5","volume":"93","author":"A Rosati","year":"2009","unstructured":"Rosati A, Tomassini A, Pollo B, Ambrosi C, Schwarz A, Padovani A, Bonetti B (2009) Epilepsy in cerebral glioma: timing of appearance and histological correlations. J Neuro-Oncol 93(3):395\u2013400","journal-title":"J Neuro-Oncol"},{"key":"4025_CR120","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/archneurol.2009.335","volume":"67","author":"A Rosati","year":"2010","unstructured":"Rosati A, Buttolo L, Stefini R, Todeschini A, Cenzato M, Padovani A (2010) Efficacy and safety of levetiracetam in patients with glioma: a clinical prospective study. Arch Neurol 67:343\u2013346","journal-title":"Arch Neurol"},{"key":"4025_CR121","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/WCO.0b013e32833e996c","volume":"23","author":"AO Rossetti","year":"2010","unstructured":"Rossetti AO, Stupp R (2010) Epilepsy in brain tumor patients. Curr Opin Neurol 23:603\u2013609","journal-title":"Curr Opin Neurol"},{"key":"4025_CR122","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/neuonc\/not170","volume":"16","author":"AO Rossetti","year":"2014","unstructured":"Rossetti AO, Jeckelmann S, Novy J, Roth P, Weller M, Stupp R (2014) Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study. Neuro-Oncology 16:584\u2013588","journal-title":"Neuro-Oncology"},{"key":"4025_CR123","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11060-017-2628-0","volume":"136","author":"R Rud\u00e0","year":"2018","unstructured":"Rud\u00e0 R, Pellerino A, Franchino F, Bertolotti C, Bruno F, Mo F, Migliore E, Ciccone G, Soffietti R (2018) Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study. J Neuro-Oncol 136:105\u2013114","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"4025_CR124","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11060-008-9749-4","volume":"92","author":"M Santisteban","year":"2009","unstructured":"Santisteban M, Buckner JC, Reid JM, Wu W, Scheithauer BW, Ames MM, Felten SJ, Nikcevich DA, Wiesenfeld M, Jaeckle KA, Galanis E, North Central Cancer Treatment Group (2009) Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North American central cancer treatment group results. J Neuro-Oncol 92(2):165\u2013175","journal-title":"J Neuro-Oncol"},{"issue":"6","key":"4025_CR125","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3171\/2013.1.JNS12397","volume":"118","author":"MG Saria","year":"2013","unstructured":"Saria MG, Corle C, Hu J, Rudnick JD, Phuphanich S, Mrugala MM, Crew LK, Bota DA, Dan Fu B, Kim RY, Brown T, Feely H, Brechlin J, Brown BD, Drappatz J, Wen PY, Chen CC, Carter B, Lee JW, Kesari S (2013) Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors: clinical article. J Neurosurg 118(6):1183\u20131187","journal-title":"J Neurosurg"},{"issue":"5","key":"4025_CR126","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3171\/2014.7.JNS132829","volume":"121","author":"ET Sayegh","year":"2014","unstructured":"Sayegh ET, Fakurnejad S, Oh T, Bloch O, Parsa AT (2014) Anticonvulsant prophylaxis for brain tumor surgery: determining the current best available evidence. J Neurosurg 121(5):1139\u20131147","journal-title":"J Neurosurg"},{"issue":"1\u20132","key":"4025_CR127","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/epi4.5","volume":"1","author":"IE Scheffer","year":"2016","unstructured":"Scheffer IE, French J, Hirsch E, Jain S, Mathern GW, Mosh\u00e9 SL, Perucca E, Tomson T, Wiebe S, Zhang YH, Zuberi SM (2016) Classification of the epilepsies: new concepts for discussion and debate\u2014special report of the ILAE Classification Task Force of the Commission for Classification and Terminology. Epilepsia Open 1(1\u20132):37\u201344","journal-title":"Epilepsia Open"},{"issue":"6","key":"4025_CR128","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.3892\/ol.2017.5988","volume":"13","author":"JM Sep\u00falveda-S\u00e1nchez","year":"2017","unstructured":"Sep\u00falveda-S\u00e1nchez JM, Conde-Moreno A, Bar\u00f3n M, Pardo J, Reyn\u00e9s G, Belenguer A (2017) Efficacy and tolerability of lacosamide for secondary epileptic seizures in patients with brain tumor: a multicenter, observational retrospective study. Oncol Lett 13(6):4093\u20134100","journal-title":"Oncol Lett"},{"issue":"12","key":"4025_CR129","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.4065\/79.12.1489","volume":"79","author":"JI Sirven","year":"2004","unstructured":"Sirven JI, Wingerchuk DM, Drazkowski JF, Lyons MK, Zimmerman RS (2004) Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc 79(12):1489\u20131494","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"4025_CR130","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/ana.24522","volume":"78","author":"M Skardelly","year":"2015","unstructured":"Skardelly M, Brendle E, Noell S, Behling F, Wuttke TV, Schittenhelm J, Bisdas S, Meisner C, Rona S, Tatagiba MS, Tabatabai G (2015) Predictors of preoperative and early postoperative seizures in patients with intra-axial primary and metastatic brain tumors: a retrospective observational single center study. Ann Neurol 78(6):917\u2013928","journal-title":"Ann Neurol"},{"issue":"4","key":"4025_CR131","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1365-2125.2009.03370.x","volume":"67","author":"DA Smith","year":"2009","unstructured":"Smith DA, Koch KM, Arya N, Bowen CJ, Herendeen JM, Beelen A (2009) Effects of ketoconazole and carbamazepine on lapatinib pharmacokinetics in healthy subjects. Br J Clin Pharmacol 67(4):421\u2013426","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"4025_CR132","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10143-016-0771-2","volume":"40","author":"G Spena","year":"2017","unstructured":"Spena G, Schucht P, Seidel K, Rutten GJ, Freyschlag CF, D\u2019Agata F, Costi E, Zappa F, Fontanella M, Fontaine D, Almairac F, Cavallo M, de Bonis P, Conesa G, Foroglou N, Gil-Robles S, Mandonnet E, Martino J, Picht T, Viegas C, Wager M, Pallud J (2017) Brain tumors in eloquent areas: a European multicenter survey of intraoperative mapping techniques, intraoperative seizures occurrence, and antiepileptic drug prophylaxis. Neurosurg Rev 40(2):287\u2013298","journal-title":"Neurosurg Rev"},{"key":"4025_CR133","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0920-1211(02)00005-0","volume":"49","author":"S Striano","year":"2002","unstructured":"Striano S, Striano P, Boccella P, Nocerino C, Bilo L (2002) Tiagabine in glial tumors. Epilepsy Res 49:81\u201385","journal-title":"Epilepsy Res"},{"issue":"3","key":"4025_CR134","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3171\/2010.5.JNS091972","volume":"114","author":"ME Sughrue","year":"2011","unstructured":"Sughrue ME, Rutkowski MJ, Chang EF, Shangari G, Kane AJ, McDermott MW, Berger MS, Parsa AT (2011) Postoperative seizures following the resection of convexity meningiomas: are prophylactic anticonvulsants indicated? Clinical article. J Neurosurg 114(3):705\u2013709","journal-title":"J Neurosurg"},{"issue":"1","key":"4025_CR135","first-page":"55","volume":"49","author":"PN Tandon","year":"2001","unstructured":"Tandon PN, Mahapatra AK et al (2001) Epileptic seizures in supratentorial gliomas. Neurol India 49(1):55\u201359","journal-title":"Neurol India"},{"issue":"3","key":"4025_CR136","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/ane.12711","volume":"136","author":"MJ Tanti","year":"2017","unstructured":"Tanti MJ, Marson AG, Jenkinson MD (2017) Epilepsy and adverse quality of life in surgically resected meningioma. Acta Neurol Scand 136(3):246\u2013253","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"4025_CR137","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00415-014-7552-z","volume":"262","author":"A Tinchon","year":"2015","unstructured":"Tinchon A, Oberndorfer S, Marosi C, Gleiss A, Geroldinger A, Sax C, Sherif C, Moser W, Grisold W (2015) Haematological toxicity of valproic acid compared to levetiracetam in patients with glioblastoma multiforme undergoing concomitant radio-chemotherapy: a retrospective cohort study. J Neurol 262(1):179\u2013186","journal-title":"J Neurol"},{"key":"4025_CR138","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.clineuro.2015.10.002","volume":"139","author":"M Toledo","year":"2015","unstructured":"Toledo M, Sarria-Estrada S, Quintana M, Maldonado X, Martinez-Ricarte F, Rodon J, Auger C, Salas-Puig, Santamarina E, Martinez-Saez E (2015) Prognostic implications of epilepsy in glioblastomas. Clin Neurol Neurosurg 139:166\u2013171","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"4025_CR139","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/ane.12809","volume":"137","author":"M Toledo","year":"2018","unstructured":"Toledo M, Molins A, Quintana M, Santamarina E, Martinez-Ricarte F, Mart\u00ednez-Saez E, Salas-Puig J (2018) Outcome of cancer-related seizures in patients treated with lacosamide. Acta Neurol Scand 137(1):67\u201375","journal-title":"Acta Neurol Scand"},{"key":"4025_CR140","first-page":"CD004424","volume":"2","author":"IW Tremont-Lukats","year":"2008","unstructured":"Tremont-Lukats IW, Ratilal BO et al (2008) Antiepileptic drugs for preventing seizures in people with brain tumors. Cochrane Database Syst Rev 2:CD004424","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"4025_CR141","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11060-010-0126-8","volume":"99","author":"JB Usery","year":"2010","unstructured":"Usery JB, Michael LM 2nd et al (2010) A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures. J Neuro-Oncol 99(2):251\u2013260","journal-title":"J Neuro-Oncol"},{"issue":"9","key":"4025_CR142","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00415-009-5156-9","volume":"256","author":"MS van Breemen","year":"2009","unstructured":"van Breemen MS, Rijsman RM, Taphoorn MJ, Walchenbach R, Zwinkels H, Vecht CJ (2009) Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol 256(9):1519\u20131526","journal-title":"J Neurol"},{"key":"4025_CR143","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1586\/era.10.48","volume":"10","author":"CJ Vecht","year":"2010","unstructured":"Vecht CJ, Wilms EB (2010) Seizures in low- and high-grade gliomas: current management and future outlook. Expert Rev Anticancer Ther 10:663\u2013669","journal-title":"Expert Rev Anticancer Ther"},{"key":"4025_CR144","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s11060-017-2473-1","volume":"133","author":"C Vecht","year":"2017","unstructured":"Vecht C, Duran-Pena A, Houillier C, Durand T, Capelle L, Huberfeld G (2017) Seizure response to perampanel in drug-resistant epilepsy with gliomas: early observations. J Neuro-Oncol 133:603\u2013607","journal-title":"J Neuro-Oncol"},{"key":"4025_CR145","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.yebeh.2016.09.033","volume":"65","author":"V Villanueva","year":"2016","unstructured":"Villanueva V, Saiz-Diaz R, Toledo M, Piera A, Mauri JA, Rodriguez-Uranga JJ, L\u00f3pez-Gonz\u00e1lez FJ, G\u00f3mez-Ib\u00e1\u00f1ez A, Garc\u00e9s M, Gonz\u00e1lez de la Aleja J, Rodr\u00edguez-Osorio X, Palao-Duarte S, Castillo A, Bonet M, Ruiz-Gim\u00e9nez J, Palau J, Arcediano A, Toledo M, Gago A (2016) NEOPLASM study: real-life use of lacosamide in patients with brain tumor-related epilepsy. Epilepsy Behav 65:25\u201332","journal-title":"Epilepsy Behav"},{"issue":"1","key":"4025_CR146","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1227\/NEU.0b013e318212badb","volume":"69","author":"ML Waagemans","year":"2011","unstructured":"Waagemans ML, van Nieuwenhuizen D, Dijkstra M, Wumkes M, Dirven CMF, Leenstra S, Reijneveld JC, Klein M, Stalpers LJA (2011) Long-term impact of cognitive deficits and epilepsy on quality of life in patients with low-grade meningiomas. Neurosurgery 69(1):72\u201379","journal-title":"Neurosurgery"},{"issue":"8","key":"4025_CR147","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S1059-1311(03)00096-7","volume":"12","author":"GL Wagner","year":"2003","unstructured":"Wagner GL, Wilms EB et al (2003) Levetiracetam: preliminary experience in patients with primary brain tumours. Seizure 12(8):585\u2013586","journal-title":"Seizure"},{"key":"4025_CR148","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00228-016-2167-1","volume":"73","author":"S Watanabe","year":"2017","unstructured":"Watanabe S, Kuwabara Y, Suehiro S, Yamashita, Tanaka M, Tanaka A, Ohue S, Araki H (2017) Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma. Eur J Clin Pharmacol 73:357\u2013363","journal-title":"Eur J Clin Pharmacol"},{"key":"4025_CR149","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1212\/WNL.0b013e31822f02e1","volume":"77","author":"M Weller","year":"2011","unstructured":"Weller M, Gorlia T, Cairncross JG, van den Bent MJ, Mason W, Belanger K, Brandes AA, Bogdahn U, Macdonald DR, Forsyth P, Rossetti AO, Lacombe D, Mirimanoff RO, Vecht CJ, Stupp R (2011) Prolonged survival with valproic acid use in the EORTC\/NCIC temozolomide trial for GBL. Neurology 77:1156\u20131164","journal-title":"Neurology"},{"issue":"16","key":"4025_CR150","doi-asserted-by":"publisher","first-page":"4899","DOI":"10.1158\/1078-0432.CCR-06-0773","volume":"12","author":"PY Wen","year":"2006","unstructured":"Wen PY et al (2006) Phase I\/II study of imatinib mesylate for recurrent malignant gliomas: North American brain tumor consortium study. Clin Cancer Res 12(16):4899\u20134907","journal-title":"Clin Cancer Res"},{"key":"4025_CR151","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/1097-0142(19951101)76:9<1634::AID-CNCR2820760921>3.0.CO;2-0","volume":"76","author":"MH Werner","year":"1995","unstructured":"Werner MH, Phuphanich S, Lyman GH (1995) The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly. Cancer 76:1634\u20131642","journal-title":"Cancer"},{"issue":"7","key":"4025_CR152","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1093\/neuonc\/nov303","volume":"18","author":"HG Wirsching","year":"2016","unstructured":"Wirsching HG, Morel C, Gmu C, Neidert MC, Baumann CR, Valavanis A, Rushing EJ, Krayenbu N, Weller M (2016) Predicting outcome of epilepsy after meningioma resection. Neuro-Oncology 18(7):1002\u20131010","journal-title":"Neuro-Oncology"},{"issue":"4","key":"4025_CR153","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3171\/2012.12.JNS111970","volume":"118","author":"AS Wu","year":"2013","unstructured":"Wu AS, Trinh VT, Suki D, Graham S, Forman A, Weinberg JS, McCutcheon IE, Prabhu SS, Heimberger AB, Sawaya R, Wang X, Qiao W, Hess KR, Lang FF (2013) A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors. J Neurosurg 118(4):873\u2013883","journal-title":"J Neurosurg"},{"issue":"11","key":"4025_CR154","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1016\/j.clineuro.2013.08.023","volume":"115","author":"T Wychowski","year":"2013","unstructured":"Wychowski T, Wang H, Buniak L, Henry JC, Mohile N (2013) Considerations in prophylaxis for tumor-associated epilepsy: prevention of status epilepticus and tolerability of newer generation AEDs. Clin Neurol Neurosurg 115(11):2365\u20132369","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"4025_CR155","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/1744-1633.12102","volume":"19","author":"P Yat-Ming Woo","year":"2015","unstructured":"Yat-Ming Woo P et al (2015) Risk factors for seizures and antiepileptic drug-associated adverse effects in high-grade glioma patients: a multicenter, retrospective study in Hong Kong. Surg Pract 19(1):2\u20138","journal-title":"Surg Pract"},{"issue":"2","key":"4025_CR156","first-page":"S337","volume":"19","author":"C Yavas","year":"2011","unstructured":"Yavas C, Zorlu F et al (2011) Prospective assessment of quality of life in adult patients treated for low grade glioma. Support Care Cancer 19(2):S337","journal-title":"Support Care Cancer"},{"key":"4025_CR157","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.seizure.2014.04.016","volume":"23","author":"Y Yuan","year":"2014","unstructured":"Yuan Y, Yunhe M, Xiang W, Yanhui L, Yanwu Y, Shuang L, Ruofei L, Jiewen L, Qing M (2014) P450 enzyme-inducing and non-enzyme-inducing antiepileptic drugs for seizure prophylaxis after glioma resection surgery: a meta-analysis. Seizure 23:616\u2013621","journal-title":"Seizure"},{"key":"4025_CR158","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.seizure.2014.06.015","volume":"23","author":"Y Yuan","year":"2014","unstructured":"Yuan Y, Xiang W, Qing M, Yanhui L, Jiewen L, Yunhe M (2014) Survival analysis for valproic acid use in adult glioblastoma multiforme: a meta-analysis of individual patient data and a systematic review. Seizure 23:830\u2013835","journal-title":"Seizure"},{"key":"4025_CR159","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jocn.2015.01.025","volume":"22","author":"Y Yuan","year":"2015","unstructured":"Yuan Y, Peizhi Z, Maling G, Wu L, Yunhe M, Xiang W, Qing M, Yanhui L, Ruofei L, Jiewen L (2015) The efficacy of levetiracetam for patients with supratentorial brain tumors. J Clin Neurosci 22:1227\u20131231","journal-title":"J Clin Neurosci"},{"issue":"1","key":"4025_CR160","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11060-010-0235-4","volume":"101","author":"I Zachenhofer","year":"2011","unstructured":"Zachenhofer I, Donat M, Oberndorfer S, Roessler K (2011) Perioperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery. J Neuro-Oncol 101(1):101\u2013106","journal-title":"J Neuro-Oncol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-04025-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-019-04025-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-04025-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T20:05:37Z","timestamp":1721592337000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-019-04025-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,7]]},"references-count":160,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["4025"],"URL":"https:\/\/doi.org\/10.1007\/s10072-019-04025-9","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,7]]},"assertion":[{"value":"24 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Marta Maschio has received support to travel to congresses from Eisai Srl, has participated in scientific advisory boards for Eisai Srl, has participated in pharmaceutical industry sponsored symposia for UCB Pharma, and has received research grants from UCB Pharma. Dr. Angela La Neve has received speaker\u2019s or consultancy fees from Eisai Srl, Mylan, Sanofi-Aventis, and UCB Pharma. Dr. Gaetano Zaccara has received speaker\u2019s or consultancy fees from Eisai Srl, Sanofi-Aventis, and UCB Pharma. Dr. Cinzia Costa has received speaker\u2019s or consultancy fees from Eisai Srl, FIDIA, Mylan, and UCB. Dr. Filippo Dainese has received speaker\u2019s or consultancy fees from Eisai and UCB Pharma. Dr. Umberto Aguglia has received research grants from Biogen. Dr. Ettore Beghi has received grants from UCB Pharma and grants from Italian Ministry of Health. Dr. Federica Ranzato has participated in hospital meetings and sponsored symposia from UCB Pharma and Eisai Srl.00. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}